Chemoradiation: Gastro-oesophageal cancer - Is CROSSing over so hard to do?

Mariela A. Blum; Jaffer A. Ajani

doi:10.1038/nrclinonc.2012.122

Chemoradiation: Gastro-oesophageal cancer - Is CROSSing over so hard to do?

Mariela A. Blum, Jaffer A. Ajani

GI Medical Oncology

Research output: Contribution to journal › Review article › peer-review

Abstract

Suboptimal studies had established preoperative chemoradiation as the preferred strategy in the management of localized oesophageal cancer (LEC) and gastro-oesophageal cancer. The recent CROSS trial has now demonstrated considerable benefit from preoperative chemoradiation over surgery alone in patients with LEC. But, are these results only reinforcing advocates of the preoperative chemoradiation strategy?

Original language	English (US)
Pages (from-to)	493-494
Number of pages	2
Journal	Nature Reviews Clinical Oncology
Volume	9
Issue number	9
DOIs	https://doi.org/10.1038/nrclinonc.2012.122
State	Published - Sep 2012

ASJC Scopus subject areas

Oncology

Access to Document

10.1038/nrclinonc.2012.122

Cite this

@article{142218cddc4f481fb0aeeb49cd9b19ab,

title = "Chemoradiation: Gastro-oesophageal cancer - Is CROSSing over so hard to do?",

abstract = "Suboptimal studies had established preoperative chemoradiation as the preferred strategy in the management of localized oesophageal cancer (LEC) and gastro-oesophageal cancer. The recent CROSS trial has now demonstrated considerable benefit from preoperative chemoradiation over surgery alone in patients with LEC. But, are these results only reinforcing advocates of the preoperative chemoradiation strategy?",

author = "Blum, {Mariela A.} and Ajani, {Jaffer A.}",

year = "2012",

month = sep,

doi = "10.1038/nrclinonc.2012.122",

language = "English (US)",

volume = "9",

pages = "493--494",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Chemoradiation

T2 - Gastro-oesophageal cancer - Is CROSSing over so hard to do?

AU - Blum, Mariela A.

AU - Ajani, Jaffer A.

PY - 2012/9

Y1 - 2012/9

N2 - Suboptimal studies had established preoperative chemoradiation as the preferred strategy in the management of localized oesophageal cancer (LEC) and gastro-oesophageal cancer. The recent CROSS trial has now demonstrated considerable benefit from preoperative chemoradiation over surgery alone in patients with LEC. But, are these results only reinforcing advocates of the preoperative chemoradiation strategy?

AB - Suboptimal studies had established preoperative chemoradiation as the preferred strategy in the management of localized oesophageal cancer (LEC) and gastro-oesophageal cancer. The recent CROSS trial has now demonstrated considerable benefit from preoperative chemoradiation over surgery alone in patients with LEC. But, are these results only reinforcing advocates of the preoperative chemoradiation strategy?

UR - http://www.scopus.com/inward/record.url?scp=84865683952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865683952&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2012.122

DO - 10.1038/nrclinonc.2012.122

M3 - Review article

C2 - 22825372

AN - SCOPUS:84865683952

SN - 1759-4774

VL - 9

SP - 493

EP - 494

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 9

ER -

Chemoradiation: Gastro-oesophageal cancer - Is CROSSing over so hard to do?

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this